A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice

NACompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

January 13, 2020

Study Completion Date

January 13, 2020

Conditions
CataractsMeibomian Gland Dysfunction (MGD)
Interventions
DEVICE

LipiFlow Thermal Pulsation System

Treatment at preoperative visit for study group

DEVICE

LipiFlow Thermal Pulsation System

Treatment at 3 month visit as the cross-over group

Trial Locations (5)

20815

Eye Doctors of Washington, Chevy Chase

75243

JW Eye Associates, P.A., Dallas

76054

Texas Eye & Laser Center, P.A., Hurst

93309

Empire Eye & Laser Center, Inc., Bakersfield

08534

Matossian Eye Associates, Pennington

All Listed Sponsors
lead

Johnson & Johnson Surgical Vision, Inc.

INDUSTRY

NCT03708367 - A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice | Biotech Hunter | Biotech Hunter